5 completed, 2 withdrawn, 1 unknown. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 5, Withdrawn 2, Unknown 1 |
Follow Trematode Infections: new trials by email Literature Review of Trematode Infections trials Research Report on Trematode Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older). Egaten (Triclabendazole) 250 mg tablets - Fascioliasis | Phase 4 | Completed | Novartis Pharmaceuticals | 301 | 2022-02-11 | 2026-11-06 |
| Synbiotics Interventions for Managing Cirrhosis and Its Complications Entecavir 0.5 mg, A 10-g packet of lactulose oral solution and three capsules of probiotics, A 10-g packet of glucose oral solution and three capsules of starch - Cirrhosis, Liver, Metagonimiasis | Phase 4 | Completed | First Affiliated Hospital of Zhejiang University | 120 | 2019-11-24 | 2023-01-18 |
| Twice Yearly Treatment for the Control of LF 400 μg/kg Ivermectin + 400 mg Albendazole - Lymphatic Filariasis, Helminth Infection | Phase 4 | Completed | Noguchi Memorial Institute for Medical Research | 1462 | 2017-05-19 | 2020-02-26 |
| Intestinal Microbiome Post-Azythromycin/Albendazole Treatment Azithromycin, Albendazole, Delayed treatment - Helminth Infection | Phase 4 | Withdrawn | University of California, San Francisco | 2017-01-01 | 2021-06-28 | |
| Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With Schistosomiasis Praziquantel - Schistosomiasis | Phase 4 | Withdrawn | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-04-06 | 2019-12-17 | |
| Effect of Schistosomiasis Mansoni on HIV Susceptibility and Female Genital Immunology Praziquantel - Schistosomiasis Mansoni, HIV | Phase 4 | Completed | University of Toronto | 34 | 2016-03-01 | 2016-10-27 |
| Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghana Artemether-lumefantrine combination plus albendazole, Artemether-lumefantrine plus Praziquantel plus Albendazole, Albendazole plus Praziquantel - Malaria, Schistosomiasis | Phase 4 | Unknown | Navrongo Health Research Centre, Ghana | 345 | 2010-12-01 | 2011-10-25 |
| Evaluation of Praziquantel Dosage for Treatment of Schistosomiasis in Brazil Praziquantel 60 mg/kg, Praziquantel 40 mg/kg - Schistosomiasis Mansoni | Phase 4 | Completed | Oswaldo Cruz Foundation | 196 | 2006-03-01 | 2015-06-17 |
Schistosomiasis (2) · Schistosomiasis mansoni (2) · Anemia (1) · Coinfection (1) · Elephantiasis, Filarial (1) · Fascioliasis (1) · Filariasis (1) · Helminthiasis (1) · Liver Cirrhosis (1) · Malaria (1)
Infections (8) · Parasitic Diseases (8) · Helminthiasis (7) · Vector Borne Diseases (5) · Digestive System Diseases (2) · Hemic and Lymphatic Diseases (2) · Liver Diseases (2) · Mosquito-Borne Diseases (2) · Nematode Infections (2) · Schistosomiasis (2) · Secernentea Infections (2) · Spirurida Infections (2) · Fibrosis (1) · Filariasis (1)
Praziquantel (4) · Albendazole (3) · Artemether, Lumefantrine Drug Combination (1) · Azithromycin (1) · Ivermectin (1) · Probiotics (1) · Starch (1) · Treatment Delay (1) · Triclabendazole (1) · entecavir (1)
First Affiliated Hospital of Zhejiang University (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Navrongo Health Research Centre, Ghana (1) · Noguchi Memorial Institute for Medical Research (1) · Novartis Pharmaceuticals (1) · Oswaldo Cruz Foundation (1) · University of California, San Francisco (1) · University of Toronto (1)
Ghana (2) · China (1) · Colombia (1) · Egypt (1) · Ethiopia (1) · Peru (1) · Turkey (Türkiye) (1) · Uganda (1) · Vietnam (1)
Abraham V Hodgson, MD, MPH, PhD (1) · Amy D Klion, M.D. (1) · Ana Lucia C Domingues, MD (1) · Annette Olsen, PhD (1) · Dziedzom K de Souza, PhD (1) · Edmund L Browne, MD, MPH, PhD (1) · Ernest C Opoku, MD, MPH (1) · Jeremy Keenan, MD, MPH (1) · Otavio S Pieri, PhD (1) · Pascal Magnussen, MD (1) · Rupert Kaul, MD/PhD (1)